Mathis C and Malbert CH |
Changes in pyloric resistance induced by erythromycin. |
1998 |
Neurogastroenterol. Motil. |
pmid:9614671
|
Bourrat E et al. |
[Rosacea with ocular involvement in a child]. |
1996 |
Ann Dermatol Venereol |
pmid:9615130
|
|
Syphilis--recommended treatment schedules, 1976. |
1976 |
Am Fam Physician |
pmid:961559
|
Krone LV |
The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease. |
1998 |
WMJ |
pmid:9617308
|
Kudoh S et al. |
Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. |
1998 |
Am. J. Respir. Crit. Care Med. |
pmid:9620913
|
Kruppa A et al. |
Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. |
1998 |
Dermatology (Basel) |
pmid:9621142
|
Widdowson CA and Klugman KP |
Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. |
1998 Apr-Jun |
Emerging Infect. Dis. |
pmid:9621199
|
Rosato A et al. |
A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624482
|
Muli F and Struthers JK |
Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624489
|
Kataja J et al. |
Different erythromycin resistance mechanisms in group C and group G streptococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624500
|
Reinert RR et al. |
In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624505
|
Roblin PM and Hammerschlag MR |
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624507
|
Souli M et al. |
In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9624540
|
Wirsing von König CH et al. |
Factors influencing the spread of pertussis in households. |
1998 |
Eur. J. Pediatr. |
pmid:9625336
|
Wandel C et al. |
Effect of CYP3A inhibition on vesnarinone metabolism in humans. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9630823
|
Stassi DL et al. |
Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9636144
|
Novaes AB et al. |
Immediate implants placed into infected sites: a histomorphometric study in dogs. |
1998 May-Jun |
Int J Oral Maxillofac Implants |
pmid:9638015
|
Havlik J and Holý M |
[Erythromycin stearate Spofa--coated tablets for pediatric practice]. |
1976 |
Cesk Pediatr |
pmid:963828
|
Shimatani T |
Involvement of cholinergic motor neurons in pharmacological regulation of gastrointestinal motility by glucagon in conscious dogs. |
1997 Aug-Oct |
J Smooth Muscle Res |
pmid:9639019
|
Oyarzún E et al. |
Antibiotic treatment in preterm labor and intact membranes: a randomized, double-blinded, placebo-controlled trial. |
1998 May-Jun |
J Matern Fetal Med |
pmid:9642605
|